Relapsing Multiple Sclerosis — Tolerability and Safety and Health Outcomes in Relapsing Multiple Sclerosis (MS) Patients
Citation(s)
A 4-month, Open-label, Multi-center Study to Explore Tolerability and Safety and Health Outcomes of FTY720 in Patients With Relapsing Forms of Multiple Sclerosis